撤回声明：基于细胞膜的仿生纳米复合材料用于耐药性表皮生长因子受体突变型肺癌的靶向治疗

Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer.

作者信息

Wu Pengying, Yin Dongtao, Liu Jiaming, Zhou Huige, Guo Mengyu, Liu Jing, Liu Yang, Wang Xiaobing, Liu Ying, Chen Chunying

机构信息

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.

Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710119, China.

出版信息

Nanoscale. 2022 Dec 8;14(47):17802. doi: 10.1039/d2nr90232j.

DOI:10.1039/d2nr90232j

PMID:36444827

Abstract

Retraction of 'Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer' by Pengying Wu , , 2019, , 19520-19528, https://doi.org/10.1039/C9NR05791A.

摘要

彭莹等著《基于细胞膜的仿生纳米复合材料用于耐药性表皮生长因子受体突变型肺癌的靶向治疗》的撤稿声明，2019年，第19520 - 19528页，https://doi.org/10.1039/C9NR05791A 。